1
sep.
2022
GlycoMScan received Eurostars grant!
GlycoMScan is excited to announce to have been awarded a EUR 550,000 Eurostars R&D grant together with partners Immundnz and TenWise. The companies will join forces in a two-year project to build a Glyco-Immunology Service Center for novel drug target discovery and optimisation of personalised medicines based on functional glyco-immunology findings.